Chargement en cours...
Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines
Chronic infections with HBV and HCV continue to be major public health problems, with hundreds of millions of people infected worldwide; this is despite the availability of both an effective prophylactic HBV vaccine for more than 3 decades and potent direct antivirals for HBV and, more recently, HCV...
Enregistré dans:
| Publié dans: | Pathog Immun |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Pathogens and Immunity
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486412/ https://ncbi.nlm.nih.gov/pubmed/28664194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20411/pai.v2i1.201 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|